Copyright © 1992 Published by Elsevier Science B.V.
Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type I familial amyloid polyneuropathy
Received 28 June 1991;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
Recently, it has been reported that transthyretin (TTR)-immunoreactive amyloid deposition with cerebral amyloid angiopathy in central nervous system is a common pathological finding in type I familial amyloid polyneuropathy (FAP). In the present study, we performed isolation and sequence analysis of TTR-related amyloid fibril protein from the meninges of a patient with type I FAP. Purified major amyloid fibril protein had a molecular weight of 15 kDa. Complete sequence analysis revealed that this amyloid fibril protein was a variant TTR with a single amino acid substitution of methionine for valine at position 30. This variant TTR is a previously unrecognized as cerebrovascular amyloid fibril protein. Furthermore, the patients with type I FAP are well known to have the variant TTR in the serum. These suggest that cerebrovascular amyloid fibril protein in type I FAP may derive from a serum precursor.
Author Keywords: Familial amyloid polyneuropathy; Cerebral amyloid angiopathy; Amyloid; Transthyretin; Amyloid fibril protein; Amino acid sequence







E-mail Article
Add to my Quick Links

Cited By in Scopus (15)





